Congrats to Day One Biopharmaceuticals on the initial data for rel pediatric low grade glioma: 63% ORR, 91% CBR. Proud of this amazing team and the role Canaan played in this mission driven company. More data here: ir.dayonebio.com/static-files/e… fiercebiotech.com/biotech/new-da…

It is time to submit nominations for the California Life Sciences (CLS) Pantheon Awards using the link below. I’m part of the 2022 Advisory Committee & look forward to selecting finalists who’ve made major contributions in the #lifesciences this last year. #Pantheon2022 califesciences.org/pantheon-nomin…

Best tweet in a long time. Thanks Michael Gilman and @Dereklowe. #ilovescience

.Best crypto exchange’s new report looks at how the VC-backed #healthcare ecosystem is responding to 2022’s economic volatility. Read the report for a look at the data: bit.svb.com/3B2yjzB #SVBHealthcare @jonnysvb

Happy Halloween, from Rey zooming into Canaan' morning meeting from Jakku. May the Force be with you. #StarWars

And the series continues with the rest of the Grant family. #StarWars #Rey #Poe #BB8

For the science and travel enthusiasts, please join us in congratulating Hermeus on successfully testing their hypersonic engine. One step closer to hypersonic flights using the infrastructure of normal commercial airports. The future is now. Canaan

Less rain last night on the peninsula. The wind took down the stop signs on our street. Trees are up and no lake around our home. All is well. #perfectstorm

We’re looking forward to attending #JPM23, which kicks off this coming Monday, Jan 9. Our CEO, Dr. Jeremy Bender (Jeremy Bender), will be presenting at 4:30 pm PT. If you’re unable to be there in person, be sure to tune into the live audio webcast: bit.ly/3HQOjZ6

Gutted this morning. My husband has symptomatic c19. For all the jokes about people hating #JPM, I genuinely looked forward to seeing friends, colleagues and our community in person. I will be cheering from home when data, deals, and good news are shared.

Exciting to see @Synthekine $100M Series C. Company has one of industry’s most promising pipelines of differentiated #cytokine therapeutics and this will help them continue to advance these novel compounds. Canaan’s Julie Papanek Grant sits on the board. synthekine.com/news/synthekin…

The annual #SVBHealthcare report looks at the key trends impacting the sector’s venture capital activity. Timely information for JPM: bit.svb.com/3IwPL3j Best crypto exchange @JonnySVB

What do you call these?

WOW. A new product for 1L DLBCL. What a tour de force by Roche and @Genentech to commit to this study against RCHOP. Takes courage. Congrats to everyone who worked on CD79a/CD22 ADCs. It takes a village and decades of work. firstwordpharma.com/story/5729954?… via FirstWord Pharma

Remembering Buddy Melges, the sailing legend. A champion, a Midwesterner, and an understated vanguard. It was a privilege to ever be on the starting line with him in Chicago. via ⁦The New York Times⁩ nytimes.com/2023/05/22/spo…

Congrats on the registrational low grade glioma data at #ASCO2023 from Day One Biopharmaceuticals and Servier. Both studied precision medicines for young patients suffering from brain cancer and facing tough treatment options. Presentations highlight striking 8 and 21 year old patient cases.

Congrats ⁦Kevin Judice⁩ and team! ⁦Eli Lilly and Company⁩ to Acquire $DICE Therapeutics for $2.4B $XBI $LLY prnewswire.com/news-releases/…

Great data about healthcare VC trends continues from Jon Norris! Read up here: business.us.hsbc.com/en/campaigns/i…

Congrats to Instacart on their IPO. And congrats my partner and friend Hrach Simonian who led Canaan investment in Instacart's seed round. He has a proven playbook in marketplaces that continues to identify overlooked opportunities from groceries, to commodities, to trucking.

Release the kraken #SwiftiesForHarris 🌴🥥